MDL-29951

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMDL-29951
Drug Alias NameMDL-29951
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNerve DegenerationEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoechst Marion Roussel Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsNerve DegenerationEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A